Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (November 30, 2005). doi:10.1152/ajpcell.00255.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/C1230    most recent
00255.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fullerton, M. D
Right arrow Articles by Bakovic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fullerton, M. D
Right arrow Articles by Bakovic, M.
Submitted on May 27, 2005
Accepted on November 28, 2005

Impaired trafficking of choline transporter like protein-1 at the plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages

Morgan D Fullerton1, Laura Wagner1, Zhongfei Yuan1, and Marica Bakovic1*

1 Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada

* To whom correspondence should be addressed. E-mail: mbakovic{at}uoguelph.ca.

The present study investigates choline transport processes and regulation of choline-transporter like protein-1 (CTL1) in human THP-1 monocytic cells and phorbol myristate 13-acetate (PMA)-differentiated macrophages. Choline uptake is saturable and therefore protein-mediated in both cell types but its transport characteristics change soon after treatments with PMA. The maximal rate of choline uptake intrinsic to monocytic cells is greatly diminished in differentiated macrophages as demonstrated by alterations in Vmax values from 1973±118 to 380±18 nmol/mg/min, when the binding affinity did not change significantly (Km values 56±8 and 53±6 µM respectively). Treatments with hemicholinim-3 effectively inhibit most of the choline uptake, establishing that a choline-specific transport protein rather than a general transporter is responsible for the observed kinetic parameters. mRNA screening for the expression of various transporters reveals that CTL1 is the most plausible candidate that possesses the described kinetic and inhibitory properties. Fluorescence-activated cell sorting analyses at various times after PMA treatments further demonstrate that the disappearance of CTL1 protein from the cell surface follows the same trend as the reduction in choline uptake. Importantly, the loss of functional CTL1 from the cell surface occurs without significant changes in total CTL1 protein or its mRNA level indicating that an impaired CTL1 trafficking is key contributing factor to the reduced choline uptake, subsequent to the PMA-induced THP-1 differentiation to macrophages.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
V. Michel, Z. Yuan, S. Ramsubir, and M. Bakovic
Choline Transport for Phospholipid Synthesis.
Experimental Biology and Medicine, May 1, 2006; 231(5): 490 - 504.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.